EBS
Emergent Biosolutions IncNYSEHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$426.59M
P/E Ratio
8.86
EPS
$0.93
Beta
2.36
52W High
$14.06
52W Low
$4.45
50-Day MA
$9.30
200-Day MA
$9.50
Dividend Yield
—
Profit Margin
7.08%
Forward P/E
2.08
PEG Ratio
0.38
About Emergent Biosolutions Inc
Emergent BioSolutions Inc., a life sciences company, focuses on providing preparedness and response products and solutions for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats (PHT). The company is headquartered in Gaithersburg, Maryland.
Fundamentals
| Revenue (TTM) | $742.90M |
| Gross Profit (TTM) | $367.30M |
| EBITDA | $208.90M |
| Operating Margin | -15.20% |
| Return on Equity | 10.50% |
| Return on Assets | 5.34% |
| Revenue/Share (TTM) | $13.89 |
| Book Value | $10.03 |
| Price-to-Book | 0.79 |
| Price-to-Sales (TTM) | 0.57 |
| EV/Revenue | 1.103 |
| EV/EBITDA | 3.27 |
| Quarterly Earnings Growth (YoY) | -55.80% |
| Quarterly Revenue Growth (YoY) | -23.60% |
| Shares Outstanding | $51.64M |
| Float | $47.11M |
| % Insiders | 1.89% |
| % Institutions | 81.20% |
Historical Volatility
HV 10-Day
57.74%
HV 20-Day
45.90%
HV 30-Day
49.74%
HV 60-Day
82.26%
HV Rank
7.1%
Volatility is currently expanding
Analyst Ratings
Consensus ($12.00 target)
2
BuyData last updated: 4/14/2026